沧州四星玻璃股份有限公司

沧州四星玻璃股份有限公司 免费

访问商铺
公司介绍
简介:

CANGZHOU FOUR-STAR GLASS CO. LTD

 

National Specialty New "Little Giant" High-quality Development Key Enterprises

 

Specialty: The enterprise focuses on the core business of neutral borosilicate glass manufacturing and sales, and has now formed an integrated production and operation system of pharmaceutical neutral borosilicate glass tubing and containers. The first high-tech enterprise in China that adopts its own technology with full intellectual property rights to produce pharmaceutical neutral borosilicate glass tubing on a large scale and in batches. The leading enterprise in the field of domestic pharmaceutical glass packaging manufacturing recommended by the China Pharmaceutical Packaging Association, the leader of domestic neutral borosilicate glass, and the icebreaker in the industry. The leading product, pharmaceutical neutral borosilicate glass, is the industrial chain of China's pharmaceutical industry. Vaccines, biochemical drugs, blood products, water injections, freeze-dried powder and other key materials in the supply chain of medium and high-end pharmaceutical packaging. China's neutral borosilicate glass shortboard products can be completely imported and replaced.

 

Fine: The enterprise has passed the ISO15378 medical packaging material quality management system and IS09001 quality management system certification. Established a fine and efficient management system and process to carry out refined production, management and service.

 

The management committee work system, the technical committee work system, the talent introduction and training system, the R&D project establishment and process management system, the instrument and equipment use and management system, and the fund management system have been formulated and implemented, which has improved the operation ability of the enterprise.

 

Special: The enterprise has successfully developed the core production technology "Cold-top All-electric Melting Vello Technology to Produce Pharmaceutical Neutral borosilicate Glass Tubing", which breaks the law of International Teaching that All-Electric Melting Vello Process cannot produce Medicinal Neutral borosilicate Glass.

 

FOUR STARS GLASS has achieved four major technological breakthroughs in the industry:

 

Successfully built the world's first Cold-Top All-Electric Melting Vello Process production of neutral borosilicate glass tubing

Neutral borosilicate glass has achieved import substitution, filled the domestic gap, and indirectly reduced the use cost of pharmaceutical enterprises and the manufacturing cost of glass enterprises;

 

Transform the industry from high-energy  and high-pollution  into energy-saving and environmental-friendly industry;

 

Take the lead in realizing intelligent manufacturing in the Pharmaceutical Packaging industry.

 

At present, there are 74 patents, including 14 invention patents and 7% of the enterprise's R&D investment.

 

Innovation: Focusing on the development of pharmaceutical neutral borosilicate glass, the company has built 23 new products and new technology research and development projects in the past three years, realized 8 new product research and development, 6 new technologies, and 9 achievements transformation, actively seized the domestic and foreign pharmaceutical packaging market.

 

The research and development has been successfully upgraded from the original one-to-two large-scale bottle-making production line to one-to-four integrated novel corona-virus vaccine bottle production line, which is the first in the domestic pharmaceutical packaging industry.

 

The new generation of information technology has been integrated and developed with the manufacturing industry, and an enterprise-level digital Internet platform has been established to realize the data interoperability of enterprises, the overall management level of enterprises has been improved, and the intelligent manufacturing of pharmaceutical neutral borosilicate glass tubing and vaccine bottles has been achieved. The traceability of the product improves the safety of use in the pharmaceutical industry.

 

查看详细
工商基本信息

股东信息专利信息资质证书

序号股东(发起人)持股比例认缴出资额认缴出出资日期
1王焕一 16.818% 2071.3万元人民币 2006-03-17
2创合鑫材(厦门)制造业转型升级基金合伙企业(有限合伙) 9.7434% 1200万元人民币 2021-12-23
3陈义梅 8.2413% 1015万元人民币 2021-12-28
4国投创合国家新兴产业创业投资引导基金(有限合伙) 8.1195% 1000万元人民币 2017-10-20
5沧州四星玻璃信息技术发展中心(有限合伙) 7.2913% 898万元人民币 2021-12-31
6北京玻龙企业管理中心(有限合伙) 6.2451% 769.15万元人民币 2021-11-02
7共青城渐智创业投资合伙企业(有限合伙) 4.3867% 540.269万元人民币 2021-11-19
8共青城吉富启盛股权投资合伙企业(有限合伙) 4.1174% 507.0994万元人民币 2021-11-19
9沧州四星玻璃资本管理中心(有限合伙) 2.8348% 349.13万元人民币 2015-05-28
10石家庄圆周军融股权投资基金中心(有限合伙) 2.5982% 320万元人民币 2018-12-20
11青岛盈科价值创业投资合伙企业(有限合伙) 2.4359% 300万元人民币 2021-04-29
12珠海星耀鸿泽股权投资基金合伙企业(有限合伙) 2.4359% 300万元人民币 2021-03-27
13淄博盈科吉运创业投资合伙企业(有限合伙) 2.4359% 300万元人民币 2021-04-29
14河北信产新材创业投资有限公司 2.0299% 250万元人民币 2012-12-20
15湖北中金瑞为股权投资基金合伙企业(有限合伙) 1.6717% 205.8824万元人民币 2013-12-18
16沧州恒泰投资中心(有限合伙) 1.6645% 205万元人民币 2015-05-28
17西西藏嘉泽创业投资有限公司 1.632% 201万元人民币 2020-12-08
18毕汝珍 1.5484% 190.7万元人民币 2010-08-12
19湖州芮泰股权投资合伙企业(有限合伙) 1.3235% 163万元人民币 2021-12-15
20河北鲲鹏饲料集团有限公司 1.2179% 150万元人民币 2021-11-01
公司地址
提示:本页 沧州四星玻璃股份有限公司在制药网黄页的介绍页,以上信息来自互联网,工商局公示或搜索引擎公开可见部分,不保证内容的真实性、准确性和合法性,制药网对此不承担任何 责任。如信息有误需要纠正或者删除,请 联系我们纠正或者删除信息。
其他企业更多